Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1188 publications
Cost-effectiveness of non-statin lipid-lowering therapies as an add-on to statins for achieving low-density lipoprotein cholesterol therapeutic targets in very high-risk patients in the Spanish setting.
Journal: Journal of medical economics
Published: October 20, 2025
Challenges in the Choice of Nonstatin Medications for Low-Density Lipoprotein-C Lowering for Cardiovascular Risk Reduction.
Journal: Journal of the American Heart Association
Published: October 09, 2025
Inclisiran (Leqvio) monotherapy for LDL-cholesterol reduction.
Journal: The Medical letter on drugs and therapeutics
Published: September 09, 2025
Oral Semaglutide Further Reduced LDL Cholesterol in a Patient with Familial Hypercholesterolemia Treated with Statins, Ezetimibe, and Evolocumab.
Journal: Internal medicine (Tokyo, Japan)
Published: August 27, 2025
Changes in non-culprit coronary lesions with PCSK9 inhibitors: the randomised, placebo-controlled FITTER trial.
Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
Published: August 19, 2025
Evolocumab Added to Statin Is Associated With Intracranial Atherosclerotic Plaque Regression Compared With Statin Alone.
Journal: Journal of the American Heart Association
Published: August 18, 2025
Combined Use of Statin and PCSK9 Inhibitor in a Pregnant Woman with Possible Familial Hypercholesterolemia and Coronary Artery Stenosis.
Journal: Journal of atherosclerosis and thrombosis
Published: August 12, 2025
Evolocumab for prevention of coronary artery bypass failure: timing is everything.
Journal: Lancet (London, England)
Published: August 12, 2025
Effect of evolocumab on saphenous vein graft patency after coronary artery bypass surgery (NEWTON-CABG CardioLink-5): an international, randomised, double-blind, placebo-controlled trial.
Journal: Lancet (London, England)
Published: July 22, 2025
Correction: Biomimetic nanocomplexes loading with evolocumab and curcumin for synergistic anti-atherosclerosis therapy in ApoE-/- mice.
Journal: Journal of nanobiotechnology
Published: July 14, 2025
Medical and Financial Consequences of Using PCSK9 Inhibitors for Managing Hypercholesterolemia in Saudi Arabia: A Historical Cohort Study.
Journal: Healthcare (Basel, Switzerland)
Published: July 08, 2025
Last Updated: 10/31/2025